BACILLUS CALMETTE-GUERIN TOKYO172 SUBSTRAIN FOR SUPERFICIAL BLADDER CANCER: CHARACTERIZATION AND ANTITUMOR EFFECT

High viability, good dispersion and efficient binding to tumor cells by BCG bacilli in the Tokyo172 preparation seem to be the main reasons for the lower clinical dose of this preparation compared with the Connaught preparation (18 vs 81 mg dry weight).